Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lippi, G.
Right arrow Articles by Guidi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lippi, G.
Right arrow Articles by Guidi, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2000; 93: 75-84
© 2000 Association of Physicians

Review

Lipoprotein(a): from ancestral benefit to modern pathogen?

G. Lippi and G. Guidi1

From the Istituto di Chimica e Microscopia Clinica, Università degli Studi di Verona, Ospedale Policlinico, Verona, 1 and 1Laboratorio di Analisi Chimico Cliniche e Microbiologiche, Istituto di Chimica e Microscopia Clinica, Università degli Studi di Verona, Centro Ospedaliero Clinicizzato, Verona, Italy

Address correspondence to Professor G. Guidi, Laboratorio di Analisi Chimico Cliniche e Microbiologiche, Centro Ospedaliero Clinicizzato di Valeggio sul Mincio, 37067 – Valeggio sul Mincio (VR), Italy. e-mail: gguidi{at}linus.univr.it

We review current concepts regarding the genetic, structural and metabolic features of lipoprotein(a), a major inherited cardiovascular pathogen. Although lipoprotein(a) is almost completely confined to a subset of primates, the hedgehog produces a lipoprotein(a)-like complex, which appears to have evolved independently from that of humans. The physiological role of lipoprotein(a) in humans is still unclear, and individuals with low or null concentrations of plasma lipoprotein(a) manifest no deficiency syndrome or disease. The integration of recent discoveries about the structure and metabolism of this unique lipoprotein particle has allowed the formulation of some hypotheses concerning the evolutionary advantages of synthesizing lipoprotein(a)-like particles.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
D. G. Hackam and S. S. Anand
Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
JAMA, August 20, 2003; 290(7): 932 - 940.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
G. Lippi, E. Arosio, M. Prior, and G. Guidi
Biochemical Risk Factors for Cardiovascular Disease in an Aged Male Population: Emerging Vascular Pathogens
Angiology, October 1, 2001; 52(10): 681 - 687.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.